| Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials S Şen, S Sabırlı, T Özyiğit, Y Üresin Therapeutic advances in chronic disease 4 (5), 232-241, 2013 | 57 | 2013 |
| Efficacy and safety of s-amlodipine 2.5 and 5 mg/d in hypertensive patients who were treatment-naive or previously received antihypertensive monotherapy S Şen, M Demir, Z Yiğit, AY Üresin Journal of Cardiovascular Pharmacology and Therapeutics 23 (4), 318-328, 2018 | 14 | 2018 |
| Legal and ethical framework for global health information and biospecimen exchange-an international perspective L Bernasconi, S Şen, L Angerame, AP Balyegisawa, D Hong Yew Hui, ... BMC medical ethics 21, 1-8, 2020 | 13 | 2020 |
| Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational … EA Voss, A Shoaibi, LYH Lai, C Blacketer, T Alshammari, R Makadia, ... EClinicalMedicine 58, 2023 | 9 | 2023 |
| Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis S Şen, E Karahan, C Büyükulaş, YO Polat, AY Üresin Anatolian Journal of Cardiology 25 (11), 753, 2021 | 8 | 2021 |
| Renin inhibitors in diabetes and hypertension: an update S Sen, B Ufuktepe, ZG Özünal, Y Üresin EXCLI journal 13, 1111, 2014 | 8 | 2014 |
| How COVID-19 changed clinical research strategies: a global survey A Bauer, A Eskat, A Ntekim, C Wong, D Eberle, E Hedayati, F Tay, H Yau, ... Journal of International Medical Research 50 (4), 03000605221093179, 2022 | 7 | 2022 |
| Chrono-pharmacological effects of antihypertensive drugs S Şen, M Kaşkal, Y Üresin European Heart Journal 41 (16), 1601-1601, 2020 | 7 | 2020 |
| Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension S Sen, N Gürel, B Ufuktepe, ZG Özünal, Ç Büyüklü, Y Üresin EXCLI journal 16, 245, 2017 | 4 | 2017 |
| Comparing the neuroprotective effects of telmisartan, perindopril, and nebivolol against lipopolysaccharide-induced injury in neuron-like cells S Şen, E Hacıosmanoğlu, ŞEN Selçuk Cureus 14 (7), 2022 | 3 | 2022 |
| The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients ZG Özünal, IA Tahirbegolli, M Baykal, B Ateş, B Tahirbegolli, Y Kılıç, ... The European Research Journal 5 (5), 853-860, 2019 | 3 | 2019 |
| COVID-19 ve RAAS İnhibitörleri ve Antikoagülan İlaçlar S ŞEN, E KARAHAN Turkiye Klinikleri COVID-19 2 (3), 55-60, 2021 | 2 | 2021 |
| Renin-angiotensin system in stress response and the effect of chronic exercise in healthy volunteers ZG Ozunal, S Sabirli, S Sen, S Karamursel, B Omer | 2 | 2020 |
| COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option? COVID-19 ve RAAS blokerleri: Aliskiren uygun bir seçenek olabilir mi? S Şen, AY Üresin Turk Kardiyol Dern Ars 48 (7), 631-634, 2020 | 2 | 2020 |
| Comparison of bleeding risk between standard ticagrelor and prasugrel therapies without de-escalation strategy S Şen European Heart Journal 44 (32), 3100-3101, 2023 | 1 | 2023 |
| Cost-Effectiveness Analysis of the Triclip™ Transcatheter Tricuspid Valve Repair System in Patients with Tricuspid Regurgitation M Kurnaz, S Ökçün, G Kahveci, S Şen, G Koçkaya Anatolian Journal of Cardiology 26 (3), 198, 2022 | 1 | 2022 |
| Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis S Sen, E Karahan, C Buyukulas, YO Polat, AY Uresin ANATOLIAN JOURNAL OF CARDIOLOGY 25 (11), 753-+, 2021 | 1 | 2021 |
| The Efficacy and Undesired Effects of High Dosage Zinc Treatment G Kockaya, B Ufuktepe, PD Kockaya, S Sen, O Altunel, Y Uresin Journal of Applied Pharmaceutical Science, 157-159, 2012 | 1 | 2012 |
| Vitamin B12 deficiency in pregnant women S Şen The Lancet 403 (10435), 1449-1450, 2024 | | 2024 |
| Drug-Drug Interactions and Their Association With Quality of Life in Patients With Hypertension N Gürel, Y Üresin, S Şen, ŞEN Selçuk Cureus 16 (3), 2024 | | 2024 |
